Inverse expression of dihydrodiol dehydrogenase and glutathione-s- transferase in patients with esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 111, Issue 2, 2004, Pages 246-251

  Wang, Liang Shun ^a,c   Chow, Kuan Chih ^b   Wu, Yu Chung ^a   Lin, Tze Yi ^b   Li, Wing Yin ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Dihydrodiol dehydrogenase; Esophageal cancer; GST; Nm23 H1

Indexed keywords

CYCLOOXYGENASE 2; DIHYDRODIOL DEHYDROGENASE; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEOSIDE DIPHOSPHATE KINASE A;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; ESOPHAGUS CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; OXIDOREDUCTASES; P-GLYCOPROTEIN; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 3142739422     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11650     Document Type: Article

References (53)

1. Wu YK, Chen PT, Fahn JP, Lin SS. Surgical treatment of esophageal carcinoma. Am J Surg 1980;139:805-9.
2. Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 1999;94:1933-40.
3. Munoz N, Crespi M, Grassi A, Qing WG, Qiong S, Cai LZ. Precursor lesions of esophageal cancer in high-risk populations in Iran and China. Lancet 1982;i:876-9.
4. Crespi M, Munoz N, Grassi A, Qiong S, Jing WK, Jien LJ. Precursor lesions of esophageal cancer in low-risk population in China: comparison with high-risk populations. Int J Cancer 1984;34:599-602.
5. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116-9.
6. Thun M., Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7.
7. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-44.
8. Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997;216:201-10.
9. Watanabe K, Fujii Y, Nakayama K, Ohkudo H, Kuramitsu S, Kagamiyama H. Nakanishi S. Hayaishi O. Structural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frog. Proc Natl Acad Sci USA 1988;85:11-5.
10. Suzuki T, Fujii Y, Miyano M, Chen LY, Takahashi T. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem 1999;274:241-8.
11. Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, Tsai CM. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 2001;61:2727-31.
12. Vogel K, Bentley P, Platt KL, Oesch F. Rat liver cytoplasmic dihydrodiol dehydrogenase. J Biol Chem 1980;255:9621-5.
13. Hara A, Taniguchi H, Nakayama T, Sawada H. Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J Biochem (Tokyo) 1990;108:250-4.
14. Hara A, Matsuura K, Tamada Y, Sato K, Miyabe Y, Deyashiki Y, Ishida N. Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. Biochem J 1996;313:373-6.
15. Shou M, Harvey RG, Penning TM. Contribution of dihydrodiol dehydrogenase to the metabolism of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in fortified rat liver subcellular fractions. Carcinogenesis 1992;13:1575-82.
16. Glatt HR, Vogel K, Bentley P, Oesch F. Reduction of benzo(a)-pyrene mutagenicity by dihydrodiol dehydrogenase. Nature 1979;277:319-20.
17. Flowers-Geary L, Harvey RG, Penning TM. Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem Res Toxicol 1993;6:252-60.
18. Shen H, Kauvar L, Tew KD. Importance of glutathione and associated enzymes in drug response. Oncol Res 1997;9:295-302.
19. Penning TM, Sharp RB. Characterization of dihydrodiol dehydrogenase in human liver and lung. Carcinogenesis 1990;11:1203-8.
20. Burczynski ME, Harvey RG, Penning TM. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinones metabolite benzo[a]pyrene-7,8-dione. Biochemistry 1998;37:6781-90.
21. Burczynski ME, Lin HK, Penning TM. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 1999;59:607-14.
22. Sparnins VL, Chuan J, Wattenberg LW. Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate. Cancer Res 1982;42:1205-7.
23. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000;9:551-6.
24. Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero OA, Poirier MC, Frye BL, Taylor PR, Weston A. Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett 2000;156:73-81.
25. van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB, Peters WH. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999;59:586-9.
26. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol 1996;62:22-9.
27. Hsieh CC, Chow. KC, Fahn HJ, Wu, YC, Huang MH, Chou KJ. Prognostic significance, of HER-2/neu overexpression in stage I adenocarcinoma of lung. Ann Thorac Surg 1998;66:1159-63.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
29. 2/E in the log rank test for survival data or incidence data. Biometrics 1973;29:579-84.
30. Mantel. N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
31. Schroeder, JJ, Crane HM, Xia J, Liotta DC, Merrill AH Jr. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1: a molecular mechanism for carcinogenesis associated With Fusarium moniliforme. J Biol Chem 1994;269:3475-81.
32. Hecker E, Lutz D, Weber J, Goerttler K, Morton JF. Multistage tumor development in the human esophagus: the first identification of cocarcinogens of the tumor promoter type as principal carcinogenic risk factors in a local life style cancer. Prog Clin Biol Res 1983;132B: 219-38.
33. Li JY. Epidemiology of esophageal cancer in China. NCI Monogr 1982;62:113-20.
34. Cheng KK. The etiology of esophageal cancer in Chinese. Semin Oncol 1994;21:411-5.
35. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst 1992;84:771-6.
36. Mellow MH, Layne EA, Lipman TO, Kaushik M, Hostetler C, Smith JC Jr. Plasma zinc and vitamin A in human squamous carcinoma of the esophagus. Cancer 1983;51:1615-20.
37. Bartsch H, Ohshima H, Pignatelli B, Calmels S. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 1992;2:272-7.
38. Heidelberger C. Chemical carcinogenesis. Annu Rev Biochem 1975;44:79-121.
39. Guengerich FP. Roles of cytochrome P-450 in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988;48:2946-54.
40. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 1982;43:4875-917.
41. Nakajima T, Wang RS, Nimura Y, Pin YM, He M, Vainio H, Murayama N, Aoyama T, Iida F. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis 1996;17:1477-81.
42. Hayes JD, Pulford DJ. The glutathione S-tansferase supergene family: regulation of GST and contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 1995;31:445-600.
43. van Lieshout EMM, Tiemessen DM, Witteman BJ, Jansen JB, Peters WH. Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium. Jpn J Cancer Res 1999;90:81-5.
44. Penning TM. Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chemico-Biological Interactions 1993;89:1-34.
45. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Invited review: role of quinones in toxicology. Chem Res Toxicol 2000;13:136-53.
46. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204.
47. Wang LS, Chow KC, Wu YC. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. Scand J Gastroenterol 2002;37:467-75.
48. Wang LS, Chow KC, Li WY, Liu CC, Wu YC, Huang MH. Clinical significance of serum soluble interleukin-2 receptor-alpha in esophageal squamous cell carcinoma. Clin Cancer Res 2000;6:1445-51.
49. Wang LS, Chow KC, Wu CW. Expression and upregulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999;80:1617-22.
50. Hsu NY, Chow KC, Chen WJ, Lin CC, Chou FF, Chen CL. Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer. Clin Cancer Res 1999;5:1752-7.
51. Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer 1999;81:469-75.
52. +-ATPase. Br J Cancer 2000;83:1209-15.
53. Deng HB, Parekh HK, Chow KC, Simpkins H. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 2002;277:15035-43.